SDC1 and hepatocellular carcinoma: For example, the inhibitor of SDC1, synstatin, was proven to reduce the expression of pro-angiogenetic factors VEGF and FGF-2 through promoting the downregulation of αVβ3 integrin in thioacetamide-induced HCC in rats [153].